IQVIA Holdings Inc. IQV

270.37 (4.65) (1.69%) as of 25 Sep
Market cap
$45.3B
P/E
33.3×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

IQVIA Holdings Inc. (IQV) P/B ratio

As of 25 September 2026, IQVIA Holdings Inc. (IQV) trades at a P/B ratio of 7.1×. Over the past ten years it has ranged from 0.0× (December 2016) to 9.3× (December 2021); the current reading is higher than 86% of that period. That is above the Diagnostics & Research industry median of 3.1× and above the Healthcare sector median of 2.5×.

P/B ratio, daily

Annual

Period P/B ratio Change
FY2025 5.8× (0.48%)
FY2024 5.9× (15.24%)
FY2023 6.9× 4.44%
FY2022 6.6× (25.78%)
FY2021 8.9× 63.76%
FY2020 5.5× 13.39%
FY2019 4.8× 41.44%
FY2018 3.4× 29.11%
FY2017 2.6× 103.58%
FY2016 1.3× —

Quarterly

Period P/B ratio Change
Jun 2026 5.1× 12.60%
Mar 2026 4.5× (22.60%)
Dec 2025 5.8× 13.68%
Sep 2025 5.1× 9.87%
42 more quarters

Against its own ten years

Low 0.0× High 9.3×
Ten-year median 4.7×
Current reading's percentile 86

P/B ratio against peers

Company P/B ratio
GH Guardant Health, Inc. compare n/m
WAT Waters Corporation compare 2.8×
DGX Quest Diagnostics Incorporated compare 3.4×
A Agilent Technologies, Inc. compare 6.6×
IQV IQVIA Holdings Inc. 7.1×
ILMN Illumina, Inc. compare 14.5×
IDXX IDEXX Laboratories, Inc. compare 25.4×
NTRA Natera, Inc. compare 32.5×
MTD Mettler-Toledo International, Inc. compare 2,372×
Diagnostics & Research industry median 3.1×
Healthcare sector median 2.5×
Market median 1.8×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on IQV